Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2Penglei Wang, Kangdong Liu, Xuechao Jia et al.|Signal Transduction and Targeted Therapy|2023Cited by 93
Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growthXuechao Jia, Kangdong Liu, Qiong Wu et al.|Journal of Experimental & Clinical Cancer Research|2023Cited by 16
Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targetsDengyun Zhao, Kangdong Liu, Yaping Guo et al.|JCI Insight|2024Cited by 12
FBL promotes hepatocellular carcinoma tumorigenesis and progression by recruiting YY1 to enhance CAD gene expressionYafei Zhi, Kangdong Liu, Yan Guo et al.|Cell Death and Disease|2025Cited by 7
RTN4IP1 Contributes to ESCC via Regulation of Amino Acid TransportersHuifang Wei, Kangdong Liu, Dengyun Zhao et al.|Advanced Science|2025Cited by 5